Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kathmann, Norbert
2007.
Die Wirksamkeit verhaltenstherapeutischer Behandlungsverfahren bei Zwangsstörungen.
Zeitschrift für Psychiatrie, Psychologie und Psychotherapie,
Vol. 55,
Issue. 4,
p.
239.
Rabinowitz, Ilan
Baruch, Yehuda
and
Barak, Yoram
2008.
High-dose escitalopram for the treatment of obsessive–compulsive disorder.
International Clinical Psychopharmacology,
Vol. 23,
Issue. 1,
p.
49.
Zohar, Joseph
2008.
Escitalopram in the treatment of obsessive–compulsive disorder.
Expert Review of Neurotherapeutics,
Vol. 8,
Issue. 3,
p.
339.
Menzies, Lara
Chamberlain, Samuel R.
Laird, Angela R.
Thelen, Sarah M.
Sahakian, Barbara J.
and
Bullmore, Ed T.
2008.
Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited.
Neuroscience & Biobehavioral Reviews,
Vol. 32,
Issue. 3,
p.
525.
Stein, Dan J.
Denys, Damiaan
Gloster, Andrew T.
Hollander, Eric
Leckman, James F.
Rauch, Scott L.
and
Phillips, Katharine A.
2009.
Obsessive–compulsive Disorder: Diagnostic and Treatment Issues.
Psychiatric Clinics of North America,
Vol. 32,
Issue. 3,
p.
665.
Figee, Martijn
and
Denys, Damiaan
2009.
New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder.
CNS Spectrums,
Vol. 14,
Issue. S3,
p.
13.
Ipser, Jonathan C.
and
Stein, Dan J.
2009.
A systematic review of the quality and impact of anxiety disorder meta-analyses.
Current Psychiatry Reports,
Vol. 11,
Issue. 4,
p.
302.
Kellner, Michael
2010.
Drug treatment of obsessive-compulsive disorder.
Dialogues in Clinical Neuroscience,
Vol. 12,
Issue. 2,
p.
187.
Stein, Dan J.
Fineberg, Naomi A.
Bienvenu, O. Joseph
Denys, Damiaan
Lochner, Christine
Nestadt, Gerald
Leckman, James F.
Rauch, Scott L.
and
Phillips, Katharine A.
2010.
Should OCD be classified as an anxiety disorder in DSM-V?.
Depression and Anxiety,
Vol. 27,
Issue. 6,
p.
495.
Matsunaga, Hisato
Hayashida, Kazuhisa
Maebayashi, Kensei
Mito, Hironori
and
Kiriike, Nobuo
2011.
A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.
International Journal of Psychiatry in Clinical Practice,
Vol. 15,
Issue. 4,
p.
263.
Koen, Nastassja
and
Stein, Dan J.
2011.
Pharmacotherapy of anxiety disorders: a critical review.
Dialogues in Clinical Neuroscience,
Vol. 13,
Issue. 4,
p.
423.
Cunill, Ruth
and
Castells, Xavier
2011.
Handbook of Schizophrenia Spectrum Disorders, Volume II.
p.
403.
Larson, Elaine L.
and
Cortazal, Manuel
2012.
Publication guidelines need widespread adoption.
Journal of Clinical Epidemiology,
Vol. 65,
Issue. 3,
p.
239.
Stein, Dan J.
Koen, Nastassja
Fineberg, Naomi
Fontenelle, Leonardo F.
Matsunaga, Hisato
Osser, David
and
Simpson, H. Blair
2012.
A 2012 Evidence-Based Algorithm for the Pharmacotherapy for Obsessive-Compulsive Disorder.
Current Psychiatry Reports,
Vol. 14,
Issue. 3,
p.
211.
Decloedt, Eric H.
and
Stein, Dan J.
2012.
Obsessive‐Compulsive Disorder.
p.
31.
Mula, Marco
2013.
Treatment of anxiety disorders in epilepsy: An evidence‐based approach.
Epilepsia,
Vol. 54,
Issue. s1,
p.
13.
Fugger, G.
and
Aigner, Martin
2014.
Eine erfolgreiche Behandlunsgkette bei Zwangsstörung.
psychopraxis. neuropraxis,
Vol. 17,
Issue. 4,
p.
13.
Kwon, Oh-Young
and
Park, Sung-Pa
2014.
Depression and Anxiety in People with Epilepsy.
Journal of Clinical Neurology,
Vol. 10,
Issue. 3,
p.
175.
Pellegrini, Luca
Garg, Kabir
Enara, Arun
Gottlieb, David Shimon
Laws, Keith R.
Albert, Umberto
and
Fineberg, Naomi A.
2022.
Repetitive Transcranial Magnetic Stimulation (r-TMS) and Selective Serotonin Reuptake Inhibitor-Resistance in Obsessive-Compulsive Disorder a Meta-Analysis and Clinical Implications.
SSRN Electronic Journal ,
Apergis-Schoute, Annemieke M.
van der Flier, Febe E.
Ip, Samantha H.Y.
Kanen, Jonathan W.
Vaghi, Matilde M.
Fineberg, Naomi A.
Sahakian, Barbara J.
Cardinal, Rudolf N.
and
Robbins, Trevor W.
2024.
Perseveration and Shifting in Obsessive-Compulsive Disorder as a Function of Uncertainty, Punishment, and Serotonergic Medication.
Biological Psychiatry Global Open Science,
Vol. 4,
Issue. 1,
p.
326.